Financial Statements — CHYM
Balance Sheet
(in billions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 |
|---|
| Cash & Equivalents | 0.54 | 0.61 | 0.45 | 0.87 |
| Total Current Assets | 1.79 | 1.74 | 1.76 | 1.74 |
| Total Assets | 2.00 | 1.95 | 1.96 | 1.90 |
| Total Current Liabilities | 0.39 | 0.34 | 0.36 | 0.36 |
| Total Liabilities | 0.59 | 0.51 | 0.52 | 0.47 |
| Retained Earnings | (3.29) | (3.32) | (3.33) | (3.27) |
| Total Stockholder Equity | 1.40 | 1.44 | 1.44 | 1.43 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 |
|---|
| Pretax Income | 28.06 | 53.91 | (44.73) | (54.44) | (924.42) |
| Tax Provision | 0.21 | 0.46 | 0.05 | 0.28 | (1.05) |
| Net Income | 27.85 | 53.46 | (44.78) | (54.72) | (923.38) |
| Basic EPS | 0.07 | 0.14 | 0.83 | (0.15) | (7.29) |
| Diluted EPS | 0.07 | 0.13 | 0.83 | (0.15) | (7.29) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 |
|---|
| Operating Cash Flow | 207.48 | 87.48 | 32.55 | 17.48 | 2.74 |
| Capital Expenditures | 9.94 | 6.62 | -- | 2.06 | 3.63 |
| Free Cash Flow* | 197.54 | 80.86 | -- | 15.43 | (0.89) |
| Investing Cash Flow | (141.94) | 127.31 | 54.80 | (423.61) | 79.13 |
| Financing Cash Flow | (86.67) | (73.36) | (65.29) | (16.97) | 449.93 |
* Derived from reported values
